feed,title,long_url,short_url
Benzinga,Analyst Views Karuna Therapeutics' New Licensing Deal 'As Intriguing',https://benzinga.com/analyst-ratings/analyst-color/23/02/30706975/analyst-views-karuna-therapeutics-new-licensing-deal-as-intriguing,https://da.gd/BhpB
